Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Webinar: High quality laboratory testing to transform the response to the global pandemic

A look at Beckman Coulter's complete testing menu for COVID-19 which includes an option for mass-antigen testing.

COVID-19 testing is critical to diagnose individuals who may spread the diseases as well as to create strategies that may aid to prevent further spread of SARS-CoV-2. There are two types of COVID-19 tests — those that are designed to detect whether a patient has an acute infection (diagnostic tests), and those intended to detect antibodies (surveillance tests).

In this webinar, you can learn more about Beckman Coulter’s High-Quality Laboratory Tests that are intended to deliver accurate and reliable results that clinicians can trust.

Learning objectives

  • Clinical utility of serology vs antigen testing
  • Barriers to mass testing
  • Low-touch testing
  • Confidence in results
  • Impact of mutations to current testing options


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Medlab Middle East 2022 | January 24 - 27 2022

Medlab Middle East is where you can feel the pulse of the medical laboratory industry. Discover innovative products, trending technology, infinite networking opportunities and more at the upcoming 2022 edition.

Connect with innovation that's changing the face of diagnostics.

Online: 5 January - 28 Febraury 2022, from your office or home
Live: 24 - 27 January 2022, Dubai World Trade Centre